| Literature DB >> 32767367 |
V Bellato1, T Konishi2, G Pellino3,4, Y An5, A Piciocchi6, B Sensi1, L Siragusa1, K Khanna7, B M Pirozzi1, M Franceschilli1, M Campanelli1, S Efetov8, G S Sica1.
Abstract
Entities:
Mesh:
Year: 2020 PMID: 32767367 PMCID: PMC7929295 DOI: 10.1002/bjs.11800
Source DB: PubMed Journal: Br J Surg ISSN: 0007-1323 Impact factor: 6.939
Preoperatively asymptomatic COVID-19 patients by the countries' risk group
| Countries by risk group | |||||
|---|---|---|---|---|---|
| Overall | High risk | Int. risk | Low risk | ||
| 936 | 330 | 242 | 364 |
| |
|
| |||||
| Everyone | 155 (16·6) | 91 (27·6) | 43 (17·8) | 21 (5·8) | <·001 |
| All oncologic patients | 42 (4·5) | 24 (7·3) | 14 (5·8) | 4 (1·1) | <·001 |
| All emergency patients | 73 (7·8) | 41 (12·4) | 22 (9·1) | 10 (2·7) | <·001 |
| Symptomatic or suspicious radiological features | 691 (73·8) | 214 (64·8) | 183 (75·6) | 294 (80·8) | ·03 |
|
| |||||
| Yes | 257 (27·5) | 170 (51·5) | 66 (27·3) | 21 (5·8) | <·001 |
| No | 679 (72·5) | 160 (48·5) | 176 (72·7) | 343 (94·2) | |
|
| |||||
| Yes | 231 (24·7) | 158 (47·9) | 55 (22·7) | 18 (4·9) | <·001 |
| No | 705 (75·3) | 172 (52·1) | 187 (77·3) | 346 (95·1) | |
|
| |||||
| Yes | 157 (16·8) | 108 (32·7) | 39 (16·1) | 10 (2·7) | <·001 |
| No | 779 (83·2) | 222 (67·3) | 203 (83·9) | 354 (97·3) | |
|
| |||||
| Yes, PPE use | 40 (26·8) | ||||
| Yes, PPE availability | 23 (15·4) | ||||
| Yes, preoperative patient testing | 55 (36·9) | ||||
| Yes, staff testing | 26 (17·4) | ||||
| Yes, staff rotation | 16 (10·7) | ||||
| Yes, COVID-19 dedicated area | 54 (36·2) | ||||
| Yes, stop elective surgeries | 31 (20·8) | ||||
| No | 27 (18·1) | ||||
|
| |||||
| Yes | 46 (30·9) | ||||
| No/I don't know | 103 (69·1) | ||||
Int: intermediate.
Percentages do not add up to 100 because of the multiple choice question.
The second survey respondents are the centers that answered ‘yes’ in the question ‘Experienced preoperatively asymptomatic patients tested positive after surgery’ (n = 149). The data are not analyzed by countries' risk group.